IDEAYA Biosciences, Inc. (IDYA) Operating margin 2020–2025
IDEAYA Biosciences, Inc. (IDYA) operating margin by fiscal year — reported operating income divided by reported revenue.
-72.8%FY2025 · since FY2020: -180.9% → -72.8%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -72.8% | +4598.2 pp |
| FY2024 | -4671.1% | -4096.2 pp |
| FY2023 | -574.9% | -452.1 pp |
| FY2022 | -122.7% | +57.2 pp |
| FY2021 | -179.9% | +1.0 pp |
| FY2020 | -180.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More IDYA financial trends
IDYA RevenueIDYA Net incomeIDYA Net marginIDYA Gross profitIDYA Gross marginIDYA Operating incomeIDYA Operating cash flowIDYA Free cash flowIDYA Capital expendituresIDYA Return on equityIDYA Stock buybacksIDYA Dividends paidIDYA Total assetsIDYA Total liabilitiesIDYA Shareholders’ equityIDYA overview →